AliveCor
AliveCor released today KardiaCare, a digital subscription service for managing heart health at home.
From mobile ECGs to tele-rehabilitation to defibrillator delivery drones, a range of new data was on display at the American Heart Association Scientific Sessions 2019.
A new SEC document reveals the company has filed for a total offering of $9.1 million.
The company has received multiple clearances as it gears up for the release of its next-generation smartphone-connected ECG platform.
Partner AliveCor also got a mysterious new FDA clearance.
AliveCor’s KardiaMobile five times more effective at detecting heart arrhythmia than standard tests…
Researchers have now called for the device to be incorporated into standard care in A&E departments.
Interim CEO Ira Bahr said that his company is undeterred by Apple's entrance into the mobile ECG market.
Also: EverlyWell's first chief marketing officer; Livongo's mental health hires.
As AI cements its role in healthcare, more and more intelligent software offerings are pursuing 510(k) and De Novo approvals.
The investigation compared tests from 204 STEMI patients presenting in five different settings.